Prior Fundoplication Does not Improve Safety or Efficacy Outcomes of Radiofrequency Ablation: Results from the U.S. RFA Registry

Journal of Gastrointestinal Surgery

Volumn 17, Issue 1, 2013, Pages 21-29

  Shaheen, Nicholas J ^a   Kim, Hannah P ^a   Bulsiewicz, William J ^a   Lyday, William D ^b   Triadafilopoulos, George ^c   Wolfsen, Herbert C ^d   Komanduri, Srinadh ^e   Chmielewski, Gary W ^f   Ertan, Atilla ^g   Corbett, F Scott ^h   Camara, Daniel S ⁱ   Rothstein, Richard I ^j   Overholt, Bergein F ^k  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Atlanta Gastroenterology Associates   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f WILLIAM BEAUMONT HOSPITAL   (United States)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^h Gastroenterology Associates of Sarasota   (United States)

ⁱ Digestive Health Physicians   (United States)

^j DARTMOUTH MEDICAL SCHOOL   (United States)

^k Gastrointestinal Associates   (United States)

more..

Author keywords

Barrett's esophagus; Efficacy; Fundoplication; Radiofrequency ablation; Safety

Indexed keywords

EID: 84871941608     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-012-2001-8     Document Type: Article

References (28)

1. Hamilton SR, Smith RR, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Human pathology. 1988; 19(8): 942-948.
2. Cameron AJ, Souto EO, Smyrk TC. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia. The American journal of gastroenterology. 2002; 97(6): 1375-1380.
3. Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. The New England Journal of Medicine. 2011; 365(15): 1375-1383.
4. Spechler SJ. Clinical practice. Barrett's esophagus. The New England Journal of Medicine. 2002; 346(11): 836-842.
5. Shaheen NJ, Richter JE. Barrett's oesophagus. Lancet. 2009; 373(9666): 850-861.
6. Oberg S, Ritter MP, Crookes PF, Fein M, Mason RJ, Gadensytatter M, Brenner CG, Peters JH, DeMeester TR. Gastroesophageal reflux disease and mucosal injury with emphasis on short-segment Barrett's esophagus and duodenogastroesophageal reflux. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract. 1998; 2(6): 547-553; discussion 553-544.
7. Dvorak K, Payne CM, Chavarria M, Ramsey L, Dvorakova B, Bernstein H, Holubec H, Sampliner RE, Guy N, Condon A, Bernstein C, Green SB, Prasad A, Garewal HS. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut. 2007; 56(6): 763-771.
8. Hak NG, Mostafa M, Salah T, El-Hemaly M, Haleem M, Abd El-Raouf A, Hamdy E. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus. Hepato-gastroenterology. 2008; 55(82-83): 442-447.
9. Fleischer DE, Overholt BF, Sharma VK, Reymunde A, Kimmey MB, Chuttani R, Chang KJ, Lightdale CJ, Santiago N, Pleskow DK, Dean PJ, Wang KK. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2. 5-year follow-up. Gastrointestinal endoscopy. 2008; 68(5): 867-876.
10. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB, Madanick RD, Chak A, Lightdale CJ. Radiofrequency ablation in Barrett's esophagus with dysplasia. The New England journal of medicine. 2009; 360(22): 2277-2288.
11. Sharma VK, Jae Kim H, Das A, Wells CD, Nguyen CC, Fleischer DE. Circumferential and focal ablation of Barrett's esophagus containing dysplasia. The American Journal of Gastroenterology. 2009; 104(2): 310-317.
12. Lyday WD, Corbett FS, Kuperman DA, Kalvaria I, Mavrelis PG, Shughoury AB, Pruitt RE. Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy. 2010; 42(4): 272-278.
13. Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut. 2009; 58(2): 295-309.
14. Zaninotto G, Attwood SE. Surgical management of refractory gastro-oesophageal reflux. The British Journal of Surgery. 2010; 97(2): 139-140.
15. Ireland AC, Holloway RH, Toouli J, Dent J. Mechanisms underlying the antireflux action of fundoplication. Gut. 1993; 34(3): 303-308.
16. Hubbard N, Velanovich V. Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus in patients with fundoplications. Surgical Endoscopy. 2007; 21(4): 625-628.
17. dos Santos RS, Bizekis C, Ebright M, DeSimone M, Daly BD, Fernando HC. Radiofrequency ablation for Barrett's esophagus and low-grade dysplasia in combination with an antireflux procedure: a new paradigm. The Journal of Thoracic and Cardiovascular Surgery. 2010; 139(3): 713-716.
18. Ouatu-Lascar R, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus. The American Journal of Gastroenterology. 1998; 93(5): 711-716.
19. Sarela AI, Hick DG, Verbeke CS, Casey JF, Guillou PJ, Clark GW. Persistent acid and bile reflux in asymptomatic patients with Barrett esophagus receiving proton pump inhibitor therapy. Archives of Surgery. 2004; 139(5): 547-551.
20. Gerson LB, Boparai V, Ullah N, Triadafilopoulos G. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors. Alimentary Pharmacology & Therapeutics. 2004; 20(6): 637-643.
21. Mann NS, Tsai MF, Nair PK. Barrett's esophagus in patients with symptomatic reflux esophagitis. The American Journal of Gastroenterology. 1989; 84(12): 1494-1496.
22. Cameron AJ. Barrett's esophagus: prevalence and size of hiatal hernia. The American Journal of Gastroenterology. 1999; 94(8): 2054-2059.
23. Zehetner J, DeMeester SR, Ayazi S, Costales JL, Augustin F, Oezcelik A, Lipham JC, Sohn HJ, Hagen JA, DeMeester TR. Long-term follow-up after anti-reflux surgery in patients with Barrett's esophagus. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract. 2010; 14(10): 1483-1491.
24. Csendes A, Burdiles P, Braghetto I, Smok G, Castro C, Korn O, Henriquez A. Dysplasia and adenocarcinoma after classic antireflux surgery in patients with Barrett's esophagus: the need for long-term subjective and objective follow-up. Annals of Surgery. 2002; 235(2): 178-185.
25. Csendes A. Results of antireflux surgery in patients with Barrett's esophagus. European Surgery. 2008; 40(4): 154-164.
26. O'Connell K, Velanovich V. Effects of Nissen fundoplication on endoscopic endoluminal radiofrequency ablation of Barrett's esophagus. Surgical Endoscopy. 2011; 25(3): 830-834.
27. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Human Pathology. 1988; 19(2): 166-178.
28. Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Toledano AY, Shyr Y, Washington K. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Human Pathology. 2001; 32(4): 368-378.